ArticlePDF AVAILABLE

Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients

Travel Medicine and Infectious Disease
DOI: 10.1016/j.tmaid.2020.101749
4Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Cite

CITATION STYLE

APA

Eljaaly, K., & Al-Tawfiq, J. A. (2020, November 1). Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients. Travel Medicine and Infectious Disease. Elsevier Inc. https://doi.org/10.1016/j.tmaid.2020.101749

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free